Clinical studies recruiting near Aberdeen

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Avera Cancer Institute-Aberdeen · Alliance for Clinical Trials in Oncology · NCT07321652 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Providence Regional Cancer System-Aberdeen · Alliance for Clinical Trials in Oncology · NCT07091617 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Aberdeen Royal Infirmary · Eli Lilly and Company · NCT07222332 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · NHS Grampian: Aberdeen Royal Infirmary · Regeneron Pharmaceuticals · NCT06091865 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · UM Upper Chesapeake Hematology and Oncology - Aberdeen · NRG Oncology · NCT05174169 Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Phase 2/Phase 3 · Scottish Brain Sciences · Exciva GmbH · NCT07284472 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Avera Cancer Institute - Aberdeen /ID# 257759 · AbbVie · NCT04928846 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · Aberdeen Royal Infirmary · Takeda · NCT06499285 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · UM Upper Chesapeake Hematology and Oncology - Aberdeen · Alliance for Clinical Trials in Oncology · NCT06876714 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Phase 3 · Royal Aberdeen Children's Hospital · Gustave Roussy, Cancer Campus, Grand Paris · NCT04221035 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Providence Regional Cancer System-Aberdeen · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Providence Regional Cancer System-Aberdeen · Canadian Cancer Trials Group · NCT06592924 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · Providence Regional Cancer System-Aberdeen · SWOG Cancer Research Network · NCT05806515 fertiShare Evaluation
NA · Aberdeen Fertility Centre · Cardiff University · NCT06587360 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type
Phase 3 · Aberdeen Royal Infirmary · Hoffmann-La Roche · NCT07351058 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Providence Regional Cancer System-Aberdeen · Alliance for Clinical Trials in Oncology · NCT04242095 ICONIC: Improving Outcomes Through Collaboration in OsteosarComa
Phase N/A · NHS Grampian Health Board · University College, London · NCT04132895 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Aberdeen Royal Infirmary · Eli Lilly and Company · NCT06119581 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Avera Cancer Institute-Aberdeen · National Cancer Institute (NCI) · NCT05256225 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Local Institution - 2105 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · UM Upper Chesapeake Hematology and Oncology - Aberdeen · National Cancer Institute (NCI) · NCT06498635 Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Phase 3 · Aberdeen Royal Infirmary · University College, London · NCT04685616 Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Phase 3 · Avera Saint Luke's Hospital · Revolution Medicines, Inc. · NCT06881784 Neural Correlates of Autistic Individuals With Anorexia Nervosa
Phase N/A · Lilian Sutton Building · University of Aberdeen · NCT07098156 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Aberdeen Royal Infirmary-Department of Oncology ( Site 0521) · Merck Sharp & Dohme LLC · NCT03486873

Look up another city

Look up another condition